Analysis of human topoisomerase I inhibition and interaction with the cleavage site +1 deoxyguanosine, via in vitro experiments and molecular modeling studies
- 1 October 2004
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 12 (19) , 5225-5235
- https://doi.org/10.1016/j.bmc.2004.06.046
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Camptothecin: current perspectivesBioorganic & Medicinal Chemistry, 2004
- Human Topoisomerase I Inhibition: Docking Camptothecin and Derivatives into a Structure-Based Active Site ModelBiochemistry, 2002
- Position-specific trapping of topoisomerase I–DNA cleavage complexes by intercalated benzo[ a ]- pyrene diol epoxide adducts at the 6-amino group of adenineProceedings of the National Academy of Sciences, 2000
- Topoisomerase I inhibitors: selectivity and cellular resistanceDrug Resistance Updates, 1999
- Crystal Structures of Human Topoisomerase I in Covalent and Noncovalent Complexes with DNAScience, 1998
- Diversity of DNA topoisomerases I and inhibitorsBiochimie, 1998
- Domains of Human Topoisomerase I and Associated FunctionsProgress in Nucleic Acid Research and Molecular Biology, 1998
- DNA TOPOISOMERASESAnnual Review of Biochemistry, 1996
- Characterization of an altered DNA catalysis of a camptothecin-resistant eukaryotic topoisomerase INucleic Acids Research, 1993
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966